C3is Inc. (NASDAQ:CISS – Get Free Report) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 257,100 shares, a drop of 44.2% from the October 31st total of 461,000 shares. Approximately 3.1% of the company’s stock are short sold. Based on an average daily volume of 184,100 shares, the short-interest ratio is presently 1.4 days.
Institutional Trading of C3is
An institutional investor recently bought a new position in C3is stock. Acadian Asset Management LLC acquired a new stake in shares of C3is Inc. (NASDAQ:CISS – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 269,366 shares of the company’s stock, valued at approximately $374,000. Acadian Asset Management LLC owned about 73.40% of C3is as of its most recent SEC filing. Institutional investors own 10.54% of the company’s stock.
C3is Trading Down 7.3 %
NASDAQ CISS traded down $0.06 on Thursday, hitting $0.76. 511,635 shares of the stock traded hands, compared to its average volume of 706,571. The company has a market capitalization of $278,920.00, a P/E ratio of 0.03 and a beta of 2.53. The stock has a 50-day moving average of $1.11 and a 200 day moving average of $1.28. C3is has a twelve month low of $0.75 and a twelve month high of $68.49.
About C3is
C3is Inc offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.
Featured Articles
- Five stocks we like better than C3is
- There Are Different Types of Stock To Invest In
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Quiet Period Expirations Explained
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- The Basics of Support and Resistance
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for C3is Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3is and related companies with MarketBeat.com's FREE daily email newsletter.